Trifolirhizin alleviates bone destruction in rheumatoid arthritis by inhibiting osteoclast differentiation through the activation of FPR2
- 23 March 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 155, 158101
Abstract
No abstract availableKeywords
Funding Information
- China Academy of Chinese Medical Sciences (CI2024E003)
- National Natural Science Foundation of China (82274177)
- National Natural Science Foundation of China (82174042)
- National Natural Science Foundation of China (82574664)
- Fundo para o Desenvolvimento das Ciências e da Tecnologia (002/2023/ALC)
- Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China (ZZ13-YQ-043)
This publication has 29 references indexed in Scilit:
- Sophorae tonkinensis radix et rhizoma: A comprehensive review of the ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics, toxicology and detoxification strategyJournal of Ethnopharmacology, 2024
- Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROSPhytotherapy Research, 2024
- Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2International Immunopharmacology, 2023
- Matrine inhibits synovial angiogenesis in collagen-induced arthritis rats by regulating HIF-VEGF-Ang and inhibiting the PI3K/Akt signaling pathwayMolecular Immunology, 2022
- Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62/Nrf2 signalingBiomedicine & Pharmacotherapy, 2021
- The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanismPhytomedicine, 2020
- Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritisBioorganic Chemistry, 2020
- Matrine regulates Th1/Th2 cytokine responses in rheumatoid arthritis by attenuating the NF‐κB signalingCell Biology International, 2017
- Biologic therapies and bone loss in rheumatoid arthritisOsteoporosis International, 2016
- Rheumatoid arthritisThe Lancet, 2016